Results 181 to 190 of about 408,394 (320)
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
From humans to AI: understanding why AI is perceived as the preferred co-creation partner. [PDF]
Liu Y, Yang Y, Xu H.
europepmc +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Co-creation process of an app for people with rare diseases - a citizen science approach. [PDF]
Schaaf J, Neff MC, Scheidt J, Storf H.
europepmc +1 more source
Supporting Collaboration and Co-Creation in LAUDS Factories Environments
Damien Evrard +2 more
openalex +2 more sources
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Unpacking the mechanisms and consequences of artificial intelligence in enabling green value co-creation for SMEs. [PDF]
Yan X, Chen YS, Lin Y.
europepmc +1 more source
Drivers and outcomes of value co-creation behaviour: Investigating the potential boundary conditions
G Laud +3 more
openalex
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source

